Sectors
MEDP
Medpace Holdings, Inc.
498.34
2 x 496.11
2 x 499.19
bid
ask
+
8.86
1.81%
2 @ 04:00 PM
498.34 +0.00 (0.00%)
Ytd -11.27%
1y 60.12%
481.36
day range
501.33
277.23
52 week range
620.59
Open 481.36 Prev Close 489.48 Low 481.36 High 501.33 Mkt Cap 14.14B
Vol 284.41K Avg Vol 341.20K EPS 15.26 P/E 32.66 Forward P/E 25.94
Beta 1.46 Short Ratio 3.69 Inst. Own 86.46% Dividend N/A Div Yield N/A
Ex Div Date N/A Earning 04-22 50-d Avg 487.40 200-d Avg 496.35 1yr Est 500.08
Earning
Date For Estimate Reported Surprise surprise %
2026-04-22 2026-03 3.74 N/A N/A N/A
2026-02-09 2025-12 4.18 4.67 0.49 11.72%
2025-10-22 2025-09 3.5 3.86 0.36 10.29%
2025-07-21 2025-06 3 3.1 0.1 3.33%
2025-04-21 2025-03 3.06 3.67 0.61 19.93%
2025-02-10 2024-12 2.97 3.67 0.7 23.57%
Upgrade / Downgrade
Date Firm Action From To
2026-03-06 Barclays Upgrade Underweight Equal-Weight
2026-03-03 RBC Capital Upgrade Outperform
2026-02-18 TD Cowen Upgrade Sell Hold
2026-02-13 Jefferies Upgrade Hold Buy
2026-02-11 Barclays Upgrade Underweight Underweight
2026-02-11 Truist Securities Upgrade Hold Hold
Profile
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Insider Holder
Date Name Relation Quantity Description
2025-11-20 BRADY KEVIN M. Chief Financial Officer 5.83K Stock Gift
2026-03-17 BURWIG SUSAN ELIZABETH Officer 70.48K Conversion of Exercise of derivative security
2026-02-12 CARLEY BRIAN T Director 32.75K Conversion of Exercise of derivative security
2025-10-29 DAVENPORT FRED B JR Director 5.50K Conversion of Exercise of derivative security
2026-02-16 EWALD STEPHEN P General Counsel 16.84K Conversion of Exercise of derivative security
2026-03-16 GEIGER JESSE J President 15.00K Conversion of Exercise of derivative security
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Blackrock Inc. 2.41M 1.20B 8.45%
2025-12-30 Vanguard Group Inc 2.26M 1.13B 7.92%
2025-12-30 AQR Capital Management, LLC 1.35M 672.61M 4.73%
2025-12-30 Geode Capital Management, LLC 667.30K 332.54M 2.34%
2025-12-30 State Street Corporation 664.89K 331.34M 2.33%
2025-12-30 Wasatch Advisors LP 648.31K 323.08M 2.27%
Fund Ownership
Report Date Organization Position Value Percentage
2026-01-30 iShares Trust-iShares Core S&P Mid-Cap ETF 712.50K 355.07M 2.49%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 708.82K 353.23M 2.48%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund 511.39K 254.84M 1.79%
2026-01-30 Invesco Exchange-Traded Fund Trust-Invesco S&P MidCap Quality ETF 321.33K 160.13M 1.13%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund 288.42K 143.73M 1.01%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund 239.65K 119.43M 0.84%